纳米粒子介导的收费式受体激活和双重免疫检查点下调对于潜在的癌症免疫疗法
Jing Liu1,2, Zhihao Zhao1, Richard Zanni1
1Department of Chemistry, University of Chicago, 929 East 57th Street, Chicago, Illinois 60637, United States.
ACS nano
|February 26, 2025
概括
本研究介绍了用于双CD47和PD-L1阻断癌症免疫治疗的PPA/HG纳米粒子. 这种新的方法有效地向瘤,增强免疫反应,同时尽量减少副作用.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- CD47和PD-L1检查点的双重阻断显示了癌症治疗的潜力.
- 单克隆抗体面临的局限性是由于在点,瘤外的免疫毒性.
研究的目的:
- 开发一种新的核心外纳米粒子,PPA/HG,用于强大的癌症免疫疗法.
- 通过实现针对性的免疫检查点封锁来克服传统抗体疗法的局限性.
主要方法:
- 合成了一种核心外纳米粒子 (PPA/HG) 与多酸:多酸酸 (PPA) 核心和一种胆固醇结合的3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 的.
- 研究了HG通过3A/c-Myc途径对CD47和PD-L1进行下调的机制.
- 评估了PPA在激活免疫细胞中类似收费受体3 (TLR3) 的作用,以增强抗瘤免疫力.
主要成果:
- PPA/HG 具有较长的血液半衰期,使瘤有效积累和药物释放.
- HG有效地降低了癌细胞上的CD47和PD-L1;PPA促进了树突细胞成熟和巨细胞再极化.
- 在临床前模型中,PPA/HG增强了T细胞透和激活,同时减少了调节性T细胞,显著抑制了瘤进展.
结论:
- PPA/HG纳米颗粒为双重CD47和PD-L1免疫检查点封锁提供了一个有希望的策略.
- 这种纳米粒子系统有效地重编程瘤微环境,以最小的毒性增强抗瘤免疫力.
- PPA/HG显示出治疗攻击性癌症的巨大潜力,如三阴性乳腺癌和胰腺管道腺癌.
关键词:
癌症免疫疗法免疫疗法分化集群 47分化集群 47分化集群基因组 lysine 脱甲基酶 3A 基因组 lysine 脱甲基酶纳米级协调聚合物纳米级协调聚合物编程细胞死亡 - - 结合物1收费类受体 3 的收费类受体.更多相关视频
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
12.3K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
563
相关概念视频
Tumor Immunotherapy
462
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cytotoxic T Cells-mediated Immune Response
826
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
826
Cancer Vaccines
325
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
